<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Le-Petross, Carisa</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">AUS Predicts Residual Nodal Disease after NAC</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-02-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">9-9</style></pages><abstract><style  face="normal" font="default" size="100%">Axillary ultrasound (after neoadjuvant chemo-therapy can help to restage axillary nodal basins for patients with clinical node-positive (cN1) breast cancer, sparing many from the morbidity associated with axillary lymph node dissection. This article reports on the results of a secondary end point of the American College of Surgeons Oncology Group (ACOSOG) Z1071 trial.</style></abstract><number><style face="normal" font="default" size="100%">53</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>